204 related articles for article (PubMed ID: 20087348)
1. Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.
Galamb O; Spisák S; Sipos F; Tóth K; Solymosi N; Wichmann B; Krenács T; Valcz G; Tulassay Z; Molnár B
Br J Cancer; 2010 Feb; 102(4):765-73. PubMed ID: 20087348
[TBL] [Abstract][Full Text] [Related]
2. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.
Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Valcz G; Leiszter K; Molnár B; Tulassay Z
Pathol Oncol Res; 2011 Sep; 17(3):503-9. PubMed ID: 21267688
[TBL] [Abstract][Full Text] [Related]
3. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
4. Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line.
Gao XQ; Han JX; Huang HY; Song B; Zhu B; Song CZ
World J Gastroenterol; 2005 Jul; 11(28):4337-43. PubMed ID: 16038031
[TBL] [Abstract][Full Text] [Related]
5. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays.
Notterman DA; Alon U; Sierk AJ; Levine AJ
Cancer Res; 2001 Apr; 61(7):3124-30. PubMed ID: 11306497
[TBL] [Abstract][Full Text] [Related]
7. COX2 inhibitor NS398 reduces HT-29 cell invasiveness by modulating signaling pathways mediated by EGFR and HIF1-α.
Bocca C; Bozzo F; Miglietta A
Anticancer Res; 2014 Apr; 34(4):1793-800. PubMed ID: 24692712
[TBL] [Abstract][Full Text] [Related]
8. [Study on the effect of COX-2's selective inhibitor on human colorectal adenoma cells proliferation].
Qiu C; Ouyang Q
Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):377-80. PubMed ID: 11798601
[TBL] [Abstract][Full Text] [Related]
9. Cell-surface markers for colon adenoma and adenocarcinoma.
Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
11. Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
Carvalho B; Sillars-Hardebol AH; Postma C; Mongera S; Terhaar Sive Droste J; Obulkasim A; van de Wiel M; van Criekinge W; Ylstra B; Fijneman RJ; Meijer GA
Cell Oncol (Dordr); 2012 Feb; 35(1):53-63. PubMed ID: 22278361
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
Elder DJ; Halton DE; Crew TE; Paraskeva C
Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
Galamb O; Sipos F; Solymosi N; Spisák S; Krenács T; Tóth K; Tulassay Z; Molnár B
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2835-45. PubMed ID: 18843029
[TBL] [Abstract][Full Text] [Related]
14. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
Leung E; McArthur D; Morris A; Williams N
Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
[TBL] [Abstract][Full Text] [Related]
18. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
[TBL] [Abstract][Full Text] [Related]
19. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.
Pesson M; Volant A; Uguen A; Trillet K; De La Grange P; Aubry M; Daoulas M; Robaszkiewicz M; Le Gac G; Morel A; Simon B; Corcos L
PLoS One; 2014; 9(2):e87761. PubMed ID: 24516561
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Herszényi L; Sipos F; Galamb O; Solymosi N; Hritz I; Miheller P; Berczi L; Molnár B; Tulassay Z
Pathol Oncol Res; 2008 Mar; 14(1):31-7. PubMed ID: 18347934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
